Navigation Links
Forging the Way Ahead to Better Drug Development for NASH Patients, Upcoming Webinar Hosted by Xtalks
Date:8/14/2019

Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research in a live session on Tuesday, September 10, 2019 at 1pm EDT to learn about two common imaging methods in NAFLD/NASH to aid with early disease diagnosis, risk stratification and effective management.

NAFLD is the most common diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple steatosis and NASH.

Patients with NAFLD are at risk of steatohepatitis and progressive liver fibrosis culminating in cirrhosis, typically over a period of decades.

Although liver biopsy is currently the gold standard for diagnosing progressive NASH, it has many drawbacks, such as sampling error, cost and risk of complications. Furthermore, it is not realistic to perform liver biopsies on all NAFLD patients.

The limitations of liver biopsy have driven a search for non-invasive NAFLD screening and risk stratification methods. Since advanced fibrosis has been proven to be prognostic of poor outcomes in NAFLD, multiple surrogate fibrosis markers have been studied, including imaging methods.

The two most prevalent imaging techniques to examine NAFLD and NASH patients are:

  •     Magnetic resonance elastography (MRE) — a technique that builds upon magnetic resonance imaging (MRI) to determine the stiffness of the liver, which can be used to determine the degree of fibrosis
  •     Proton density fat fraction (PDFF) — an MRI technique that can accurately determine the amount of fat in the liver (steatosis)

In this free webinar, the featured speaker will discuss these imaging methods, how they may be used for NAFLD/NASH screening, diagnosis & risk stratification, and other imaging techniques that may provide value in NAFLD/NASH patients.

For more information or to register for this event, visit Imaging for NAFLD/NASH: Current State and Future Trends.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Candice Tang
Tel: +1 (416) 977-6555 ext 400
Email: ctang@xtalks.com

Read the full story at https://www.prweb.com/releases/forging_the_way_ahead_to_better_drug_development_for_nash_patients_upcoming_webinar_hosted_by_xtalks/prweb16500313.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Forging iron women
2. 7 new GSA Bulletin articles posted online ahead of print
3. Staying ahead of Huntingtons disease
4. JCI online ahead of print table of contents for March 25, 2014
5. JCI online ahead of print table of contents for April 8, 2014
6. JCI online ahead of print table of contents for April 17, 2014
7. JCI online ahead of print table of contents for May 1, 2014
8. JCI online ahead of print table of contents for May 27, 2014
9. JCI online ahead of print table of contents for June 2, 2014
10. Racing ahead of disease outbreaks: $12 million in new research grants
11. Cybrexa Therapeutics Expands Scientific Advisory Board Ahead of IND Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... provides personalized, easy-to-understand, web-based genetic counseling, today announced that the company has expanded ... to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded ...
(Date:7/19/2019)... ... 2019 , ... VetStem Biopharma has long been a leader in ... result of a two-year research collaboration with Calidi Biotherapeutics, VetStem has signed a worldwide ... VetStem should be able to fast-track this cancer therapy for use in dogs ...
(Date:7/17/2019)... Pa. (PRWEB) , ... July 15, 2019 , ... ... of computational science expertise exclusively for Life Sciences and Healthcare companies, announces the ... provide critical advisory services and strategic direction to start-up and emerging bio-pharma companies ...
Breaking Biology News(10 mins):
(Date:7/30/2019)... ... 2019 , ... The summer season has been super busy ... has the company already hosted many of its signature cooking classes and team-building ... , With Lajollacooks4u’s Private Cooking Parties, guests prepare and enjoy a variety of ...
(Date:7/19/2019)... Calif. (PRWEB) , ... July 18, 2019 , ... ... also known as “Ravi Everest,” will be joining forces with California-based charity Coalition ... held from July 20-22nd. Coalition Duchenne raises awareness and funding for Duchenne muscular ...
(Date:7/11/2019)... , ... July 11, 2019 , ... At the most ... complimentary regenerative therapies to eight military Veterans under the R3 Heroes Program. The Veterans ... , The R3 Heroes Program allow anyone to nominate a military Veteran, teacher or ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research ... physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. ... characteristic differentiation peak, change in crystallite size , Over 142% increase in ...
Breaking Biology Technology: